| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |